Browsing by Author "Hefni, Eman"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Restricted EPIGENETIC AND TRANSCRIPTIONAL DYNAMIC IN PERIODONTAL DISEASE(University of North Carolina at Chapel Hill, 2017-03-19) Hefni, Eman; Barros, SilvanaObjectives: Several studies have shown the involvement of epigenetics with periodontal disease. Since functional dissociation of Paracellular permeability is expected during bacterial infection, we hypothesize that the methylation of host oral epithelial DNA represents an important element in the disruption of barrier function and pathogenesis of periodontal diseases. With this In vitro study, we aimed to assess whether there is altered epithelial permeability measuring trans epithelial resistance after Porphyromonas gingivalis (P. gingivalis), Campylobacter rectus (C. rectus) and Fusobacterium nucleatum (F. nucleatum) infection. Plakophilin2 (PKP2) methylation status and expression levels were also investigated. In addition, investigate the potential effects of DNA methyltransferase (DNMT) inhibitors on epithelial barrier function in response to infection with periodontal pathogen in human gingival epithelial cells. Methods: Primary human gingival epithelial cells (HGEPs) were stimulated with P. gingivalis, strain, C. rectus and F. nucleatum (MOI 50) either in the presence or absence of DNMT inhibitors (10 μM of RG108 or EGCG). CellTiter-Blue® Cell Viability Assay (Promega) was used to determine an optimum cell density and maximum inhibitor concentration at which cell viability is maintained. Transepithelial electrical resistance (TER) at various time points were performed using an EVOM® electrical resistance system. DNA methylation was quantified by PCR using EpiTect Methyl II PCR Primer Assays for PKP2. Immunofluorescence analysis was performed using PKP2 antibody and analysis performed using Zeiss710 confocal microscope. Results: Exposure of HGEPs to P. gingivalis resulted in decreased TER (P=<0.001) associated with increased cell permeability. Methylation assays showed increased methylation levels of the PKP2 in comparison to non-infected controls (P=<0.001) and an associated PKP2 down-regulation (P=<0.005). For infected cells treated with DNMT inhibitors, PKP2 mRNA expression was increased (P=<0.001) and TER values similar to non-infected cells. Comparatively, immunofluorescent staining of the PKP2 protein showed reduced protein expression in infected cells not treated with DNMT inhibitors. Conclusion: DNA methylation levels of PKP2 can affect epithelial barrier function potentially conferring increased susceptibility to infection. DNMT inhibitors can affect cell adhesion dissociation in response to infection minimizing the disturbance to the barrier function.12 0Item Restricted The Role of Angiopoietin-Like 4 in Head and Neck Squamous Cell Carcinoma Progression and Dissemination(University of Maryland, 0022-07-19) Hefni, Eman; Montaner, SilviaDysregulation of cellular signaling and behavior are instrumental in promoting tumor cell metabolism, proliferation, tissue invasion and metastasis. Extensive investigations in human cancer development have identified various of these alterations within tumors and their microenvironments that have helped guide the direction of drug development in cancer. Different types of molecular-based therapies for this disease are designed to modulate or interact with cell surface receptors (monoclonal antibodies), intracellular cascades (small molecule tyrosine kinase inhibitors) as well as microenvironment components related to the functionality of the extracellular matrix, tumor vasculature and immune response. To design these cancer molecular-based therapies, an improved understanding of the molecular underpinnings leading to tumor formation and growth is essential. The overall aim of our investigation is the identification of the molecular mechanisms associated with the induction of tumor cell migration and proliferation induced by Angiopoietin-like 4 (ANGPTL4), a pro-tumorigenic and pro- angiogenic factor, in head and neck cancer squamous cell carcinoma (HNSCC). HNSCC accounts for approximately 900,000 cases and over 400,000 deaths annually, with around 54,000 new cases and 11,000 deaths per year in the United States. Unfortunately, the clinical management of this tumor remains challenging and there is an urgent need for novel therapeutic alternatives. Our studies, divided into two research aims, use in vitro cell- based models together with signal transduction and cell and molecular biology methods. Our results demonstrate that: 1) ANGPTL4 is upregulated in human-derived dysplastic oral keratinocytes (DOKs) and HNSCC cell lines, but not in normal oral keratinocytes (NOKs), suggesting an early and sustained role for ANGPTL4 in disease progression. ANGPTL4 is a molecular marker in biopsies from patients with mild-moderate or moderate oral epithelial dysplasia, primary HNSCC and metastatic HNSCC. ANGPTL4 is necessary and sufficient to promote cell migration in DOKs and HNSCCs lines. Binding of ANGPTL4 to neuropilin-1 (NRP1) leads to paxillin (PXN) phosphorylation and cell migration in an ABL1-dependent manner, exposing the ANGPTL4/NRP1/ABL1/PXN cascade as a vulnerable target for HNSCC treatment. 2) Epidermal Growth Factor (EGF)- and Hypoxia-inducible Factor-1 (HIF-1)-mediated pathways cooperate in the upregulation of ANGPTL4 in normal and dysplastic oral keratinocytes and HNSCC cells. Besides EGF, the EGF ligand, amphiregulin leads to an increase in ANGPTL4 and is upregulated in HNSCC lesions. ANGPTL4 activates the HNSCC molecular markers p38 MAPK, AKT and mTOR in NOKs; these kinases may act as potential intracellular regulators of the autocrine signals and paracrine secretions that ANGPTL4 activates to promote HNSCC tumorigenesis. Collectively, our findings are clinically relevant and suggest that ANGPTL4 and its associated signaling molecules are potential therapeutic targets in HNSCC clinical management.14 0